$8 Billion And Counting: Pharma Paying Its ACA Taxes
This article was originally published in RPM Report
Executive Summary
HHS OIG report shows pharma industry fee is being paid, albeit with a few bumps along the way.
You may also be interested in...
Strategies To Ease Short-Term Earnings Pain From Health Reform Include Cost-Cutting, Diversification
With market-based fees and increased Medicaid rebates set to start several years before drug manufacturers will see any benefit of an expanded market from health care reform, consultants are suggesting several ways to counter the short-term negative effect on earnings, including continued cost-cutting and diversification
US Medicare Plans 'Can' Cover Wegovy, CMS Says, But Will They?
Medicare is making clear that Part D ‘can’ cover GLP-1 inhibitors that are approved for cardiovascular indications – but in language that seems to leave plans considerable discretion for now. The formulary review process for 2025 may be a more important milestone for changes.
An Artificial Intelligence Milestone For US FDA
A project to validate a depression severity measurement tool that employs artificial intelligence for use in drug trials is moving forward at FDA. The milestone is a sign of things to come – and of the incremental process for AI adoption by the regulator.